PE70398A1 - Sales de 10-aminoalifatil-dibenz [b,f] oxepina con actividad antineurodegenerativa - Google Patents
Sales de 10-aminoalifatil-dibenz [b,f] oxepina con actividad antineurodegenerativaInfo
- Publication number
- PE70398A1 PE70398A1 PE1997000433A PE00043397A PE70398A1 PE 70398 A1 PE70398 A1 PE 70398A1 PE 1997000433 A PE1997000433 A PE 1997000433A PE 00043397 A PE00043397 A PE 00043397A PE 70398 A1 PE70398 A1 PE 70398A1
- Authority
- PE
- Peru
- Prior art keywords
- formula
- compounds
- alkyl
- substituted
- salts
- Prior art date
Links
- 230000002555 anti-neurodegenerative effect Effects 0.000 title 1
- ATYBXHSAIOKLMG-UHFFFAOYSA-N oxepin Chemical compound O1C=CC=CC=C1 ATYBXHSAIOKLMG-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 3
- -1 AMINO GROUP Chemical group 0.000 abstract 2
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000006408 oxalic acid Nutrition 0.000 abstract 1
- 208000027232 peripheral nervous system disease Diseases 0.000 abstract 1
- 208000033808 peripheral neuropathy Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/14—[b,f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: ALK DE PREFERENCIA ES ALQUILIDENO INFERIOR; R ES UN GRUPO AMINO INSUSTITUIDO O SUSTITUIDO, POR ALQUILO C1-C4, POR FENILALQUILO C1-C4 (EN DONDE LA PARTE ALQUILICA ESTA SUSTITUIDA POR CARBOXI EVENTUALMENTE ESTERIFICADO), POR FENILALQUILENO C1-C4 O POR FENILALQUILO C1-C4-ALQUILENO C1-C4, ENTRE OTROS; R1, R2, R3 Y R4 SON H, ALQUILO C1-C4, ALCOXI C1-C4, HALOGENO, CF3. TAMBIEN SE REFIEREN A LAS SALES DE ADICION DE LOS COMPUESTOS DE FORMULA (I) Y AL PROCEDIMIENTO DE PREPARACION DE DICHA SAL, QUE COMPRENDE HACER REACCIONAR EL COMPUESTO DE FORMULA (I) EN FORMA LIBRE CON UN ACIDO ORGANICO TAL COMO EL ACIDO OXALICO, FUMARICO, MALEICO, SUCCINICO, DIMALEICO O DIFUMARICO, ENTRE OTROS. LOS COMPUESTOS DE FORMULA (I) Y SUS SALES DE ADICION SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES NEURODEGENERATIVAS ESPECIALMENTE AQUELLAS RELACIONADAS A LA MUERTE CELULAR APOPTOTICA, TAL COMO ISQUEMIA CEREBRAL, LAS ENFERMEDADES DE ALZHEIMER, HUNTINGTON Y PARKINSON, LA ESCLEROSIS MULTIPLE Y LAS DIVERSAS CLASES DE GLAUCOMA, ASI COMO TAMBIEN EN EL TRATAMIENTO DE NEUROPATIAS PERIFERICAS GENERALES O DIABETICAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH135296 | 1996-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE70398A1 true PE70398A1 (es) | 1998-11-09 |
Family
ID=4208469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000433A PE70398A1 (es) | 1996-05-30 | 1997-05-28 | Sales de 10-aminoalifatil-dibenz [b,f] oxepina con actividad antineurodegenerativa |
Country Status (10)
| Country | Link |
|---|---|
| AR (1) | AR008371A1 (es) |
| AU (1) | AU3030397A (es) |
| CO (1) | CO5080765A1 (es) |
| CZ (1) | CZ296134B6 (es) |
| ID (1) | ID18178A (es) |
| PE (1) | PE70398A1 (es) |
| PL (1) | PL191728B1 (es) |
| TR (1) | TR199802482T2 (es) |
| WO (1) | WO1997045422A1 (es) |
| ZA (1) | ZA974802B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1182200T3 (da) * | 1999-06-03 | 2005-12-27 | Nippon Suisan Kaisha Ltd | Tricykliske kondenserede heterocykliske forbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf |
| US7355042B2 (en) | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| AU2003235799A1 (en) * | 2002-01-08 | 2003-07-24 | Nordic Bioscience A/S | Modulation of iamt (pimt or pcmt) in immune system |
| EP1589963A1 (en) * | 2003-01-29 | 2005-11-02 | Novartis AG | Use of 10-aminoaliphatyl-dibenz b,f oxepines for the tr eatment of degenerative ocular disorders |
| PE20050487A1 (es) * | 2003-11-06 | 2005-10-07 | Novartis Ag | Composiciones farmaceuticas estabilizadas |
| ATE542536T1 (de) | 2004-09-21 | 2012-02-15 | Hypnion Inc | 3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen |
| US7563785B2 (en) | 2004-10-29 | 2009-07-21 | Hypnion, Inc. | Quetiapine analogs and methods of use thereof |
| EP1757284A1 (en) | 2005-08-25 | 2007-02-28 | Santhera Pharmaceuticals (Schweiz) AG | Use of N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy |
| EP1842539A1 (en) * | 2006-04-05 | 2007-10-10 | Santhera Pharmaceuticals (Schweiz) AG | Use of N- (dibenz(b,f)oxepin-10-ylmethyl)N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency |
| US9937144B2 (en) | 2013-01-30 | 2018-04-10 | The Johns Hopkins University | Treatment of drug abuse by preventing GAPDH nitrosylation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3100207A (en) * | 1959-07-08 | 1963-08-06 | Smith Kline French Lab | 10-aminoalkylbenzo[b,f]thiepin and -dibenz[b,f]oxepin derivatives |
| DE1493782B1 (de) * | 1964-06-29 | 1969-12-11 | Geigy Ag J R | Basisch substituierte Dibenzo[b,f]-oxepine und deren nicht-toxische Salze |
| CH585747A5 (es) * | 1973-06-08 | 1977-03-15 | Hoffmann La Roche | |
| ES2160790T3 (es) * | 1995-02-08 | 2001-11-16 | Novartis Ag | 10-aminoalifatil-dibenzo(b,f)oxepinas de accion antineurodegenerativa. |
-
1997
- 1997-05-27 AR ARP970102247A patent/AR008371A1/es unknown
- 1997-05-28 AU AU30303/97A patent/AU3030397A/en not_active Abandoned
- 1997-05-28 WO PCT/EP1997/002794 patent/WO1997045422A1/en not_active Ceased
- 1997-05-28 PE PE1997000433A patent/PE70398A1/es not_active IP Right Cessation
- 1997-05-28 CZ CZ0387898A patent/CZ296134B6/cs not_active IP Right Cessation
- 1997-05-28 PL PL330238A patent/PL191728B1/pl unknown
- 1997-05-28 TR TR1998/02482T patent/TR199802482T2/xx unknown
- 1997-05-29 CO CO97029926A patent/CO5080765A1/es unknown
- 1997-05-30 ID IDP971845A patent/ID18178A/id unknown
- 1997-05-30 ZA ZA974802A patent/ZA974802B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5080765A1 (es) | 2001-09-25 |
| ZA974802B (en) | 1998-11-30 |
| PL330238A1 (en) | 1999-05-10 |
| CZ296134B6 (cs) | 2006-01-11 |
| PL191728B1 (pl) | 2006-06-30 |
| TR199802482T2 (xx) | 1999-02-22 |
| AU3030397A (en) | 1998-01-05 |
| ID18178A (id) | 1998-03-12 |
| AR008371A1 (es) | 2000-01-19 |
| CZ387898A3 (cs) | 1999-02-17 |
| WO1997045422A1 (en) | 1997-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE70398A1 (es) | Sales de 10-aminoalifatil-dibenz [b,f] oxepina con actividad antineurodegenerativa | |
| KR880011111A (ko) | 치환된 9-아미노-테트라하이드로아크리딘 및 그의 관련화합물, 그들의 제조방법 및 약제로서의 그들의 용도 | |
| KR890701567A (ko) | 헤테로사이클릭 화합물 | |
| ES2033316T3 (es) | Procedimiento para preparar derivados de 4-aminoquinolina. | |
| PT88307A (pt) | Processo de preparacao de uma composicao para a imunizacao de plantas contra microrganismos fitopatogenicos contendo derivados de 1,2,3-benzotiadiazol | |
| KR870001151A (ko) | 지질분해 활성을 갖는 신규 페닐에탄올 아미노테트랄린의 제조방법 | |
| AU529257B2 (en) | Controlling parasites using 2-aryl-1,3-cyclohexanedione | |
| PE20000055A1 (es) | Compuestos de indol 2,3-sustituidos como agentes anti-inflamatorios y analgesicos | |
| DK0599890T3 (da) | Geneserinderivater som cholinesteraseinhibitorer | |
| KR910004631A (ko) | 2-옥소-3,8-디아자스피로[4,5]데칸 유도체와 그것을 함유하는 약제학적 조성물 및 그 제조방법 | |
| KR910009157A (ko) | 제초성 조성물 | |
| GT200000049A (es) | Compuestos quimicos. | |
| PT96030A (pt) | Processo para a preparacao de aminocarbonilcarbamatos relacionados com fisoestigmina e de composicoes farmaceuticas que os contem | |
| ES2038202T3 (es) | Derivados de alcanos trifluorometil insecticidos. | |
| ES8701145A1 (es) | Un procedimiento para la preparacion de derivados de tetrahidronaftaleno. | |
| KR900012890A (ko) | 환-치환된 2-아미노-1,2,3,4-테트라하이드로 나프탈렌 및 3-아미노크로만 | |
| KR900014338A (ko) | 제초적 1,3,5-트리아진-2-일아미노카르보닐아미노 술포닐벤조산 에스테르, 이들의 제조방법 이들을 사용하는 제초방법 | |
| PE20030517A1 (es) | Composicion fungicida a base de al menos un derivado de piridil-metil-benzamida y de al menos un derivado ditio-carbamato | |
| ES8602626A1 (es) | Procedimiento de preparar compuestos oxima o-substituida | |
| PE20241633A1 (es) | Inhibidores de protoporfirinogeno oxidasa | |
| ES8306742A1 (es) | "un procedimiento para la preparacion de 4-(4-imidazolil)-piridinas 2-sustituidas". | |
| AR005226A1 (es) | Herbicidas de 3-fenil-pirazol sustituidos | |
| HUP9701364A2 (hu) | Eljárás {1-metil-2-[3-(trifluor-metil)-fenil]-etil}-amin (R)- és (S)-izomereinek előállítására, és az izomerek és sóik | |
| ES2038708T3 (es) | Metodo para producir compuestos de benzotiepino(5,4-c)piridazina. | |
| ES2074618T3 (es) | 3-(1h-indazol-3-il)-4-piridinaminas, un procedimiento e intermediarios para su preparacion y su uso como medicamentos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| MK | Expiration of term |